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Background: Thienopyridines (T) are critical for treatment in patients undergoing PCI. There is unexplained variability in their level of platelet 
inhibition. Given T form an acidic aqueous solution, we investigated whether they form S-nitrosylated derivatives through their critical thiol group 
without metabolic transformation.
Methods: Ticlopidin, clopidogrel and prasugrel were crushed into aqueous solution and sodium nitrite, or albumin-SNO added to study 
thienopyridine-SNO formation. Fluorescence/Ozone-based chemiluminescence techniques were utilised to specifically detect free thiol and NO 
release from the SNO produced, respectively.
Results: All 3 thienopyridines formed SNO under laboratory conditions. Thienopyridine SNO formation was largely dependent on extent of free thiol 
and pH, with prasugrel-SNO being formed more readily. Thienopyridine-SNO readily participated in trans-nitrosation reactions with albumin and 
plasma protein typically attributable to SNO chemistry.
Conclusions: Thienopyridines form an acidic solution and have sufficient free thiol - ideal conditions for SNO formation directly from the prodrug 
A low pH is key to the efficiency of SNO formation. These in vitro conditions mimic conditions found on ingesting thienopyridines into the stomach - 
low pH and ample supply of nitrite. Thienopyridine SNO formation can occur and result in bioactivity without enzymatic biotransformation and may 
explain the pleiotropic vascular and platelet effects of these agents. 
